Received Feb 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | AMAA989A | — |
patient received an expired dose of Menveo; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 22-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number AMAA989A, expiry date 30-NOV-2024) for prophylaxis. On an unknown date, the patient received Menveo. On an unknown date, an unknown time after receiving Menveo, the patient experienced expired vaccine used (Verbatim: patient received an expired dose of Menveo). The outcome of the expired vaccine used was unknown. Additional Information: GSK receipt date: 21-JAN-2025 Other HCP reported that they administered an expired dose of Menveo (2 vial), the powder portion expired on 30th Nov, 2024, which led to expired product used. Reporter asked that they have to revaccinate the patient.